J. Poupard

发表

Interpretive categorical accuracy of fluoroquinolone reference broth microdilution MIC results when testing Streptococcus pneumoniae: selection of a surrogate testing agent.

Ronald N. Jones, L. Koeth, H. Sader, 2008, Diagnostic microbiology and infectious disease.

The Alexander Project: the benefits from a decade of surveillance.

M. Jacobs, L. Miller, P. Appelbaum, 2005, The Journal of antimicrobial chemotherapy.

High-level penicillin resistance among isolates of enterococci. Implications for treatment of enterococcal infections.

M. Wendeler, L. Bush, J. Calmon, 1989, Annals of internal medicine.

Comparison of cation-adjusted Mueller-Hinton broth with Iso-Sensitest broth for the NCCLS broth microdilution method.

I. Phillips, A. King, L. Koeth, 2000, The Journal of antimicrobial chemotherapy.

Susceptibilities of nontuberculosis mycobacterial species to amoxicillin-clavulanic acid alone and in combination with antimycobacterial agents

J. Poupard, T. Moore, P. Actor, 1995, Antimicrobial agents and chemotherapy.

Tropical neuromyelopathies and retroviruses: a review.

E. Defreitas, J. Poupard, J. Vernant, 1990, Reviews of infectious diseases.

Evaluation of 500 gram negative isolates to determine the number of major susceptibility interpretation discrepancies between the Vitek and MicroScan Walkaway for 9 antimicrobial agents.

L. Miller, J. Poupard, S. Rittenhouse, 1996, Diagnostic microbiology and infectious disease.

Interpretive criteria for testing susceptibility of staphylococci to mupirocin

L. Miller, J. Poupard, J. Finlay, 1997, Antimicrobial agents and chemotherapy.

Preparations pharmaceutiques a base d'acide clavulanique et d'un agent antimycobacterien

J. Poupard, 1994 .

Risk Factors for Development of Multiple-Class Resistance to Streptococcus pneumoniae Strains in Belgium over a 10-Year Period: Antimicrobial Consumption, Population Density, and Geographic Location

R. Mera, J. van Eldere, H. Amrine-Madsen, 2007, Antimicrobial Agents and Chemotherapy.

A Comparative In Vitro Surveillance Study of Gemifloxacin Activities against 2,632 Recent Streptococcus pneumoniaeIsolates from across Europe, North America, and South America

J. Karlowsky, D. Hoban, L. Miller, 2000, Antimicrobial Agents and Chemotherapy.

Temporal and Spatial Distribution of Clonal Complexes of Streptococcus pneumoniae Isolates Resistant to Multiple Classes of Antibiotics in Belgium, 1997 to 2004 (cid:1)

W. Halsey, R. Mera, H. Amrine-Madsen, 2008 .

Is the pharmaceutical industry responding to the challenge of increasing bacterial resistance

J. Poupard, 2006 .

Comparison of mupirocin susceptibility of nasal and nonnasal Staphylococcus aureus isolates.

J. Poupard, S. Rittenhouse, L. J. Utrup, 1994, Diagnostic microbiology and infectious disease.

Transactions of the American Philosophical Society.

J. Poupard, James Poupard, 1841 .

A survey of beta-lactamase-producing Haemophilus influenzae. An evaluation of 5750 isolates.

R. L. Kaplan, L. Miller, J. Poupard, 1995, Diagnostic microbiology and infectious disease.

Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.

G. Woodnutt, B. Wynne, C. Kaye, 2004, The Journal of antimicrobial chemotherapy.

Biology of the bifidobacteria

R. Norris, J. Poupard, I. Husain, 1973, Bacteriological reviews.

Correlation of minimum inhibitory concentration results between the Vitek system and the BIOMIC system.

J. Poupard, T. Wolfram, C. Mcfarland, 1994, Advances in experimental medicine and biology.

The evolution of antimicrobial susceptibility testing methods.

J. Poupard, S. Rittenhouse, L. R. Walsh, 1994, Advances in experimental medicine and biology.

Effect of storage of Mueller-Hinton agar plates on zone sizes for antimicrobial testing.

H. Morton, J. Poupard, L. B. Dewees, 1970, Applied microbiology.

Antimicrobial Susceptibility Testing

James A. Poupard, J. Poupard, Lori R. Walsh, 1994, Advances in Experimental Medicine and Biology.

A 5-Year Surveillance Study of 44,691 Isolates ofHaemophilus influenzae Project Beta-Alert 1993–1997

R. L. Kaplan, L. Miller, J. Poupard, 1999, Antimicrobial Agents and Chemotherapy.

Comparative In Vitro Potency of Gemifloxacin and Fluoroquinolones Against Recent European Clinical Isolates from a Global Surveillance Study

D. Hoban, G. Zhanel, L. Miller, 2001, European Journal of Clinical Microbiology & Infectious Diseases.

In vitro antibacterial activity of gemifloxacin and comparator compounds against common respiratory pathogens.

K. Coleman, J. Poupard, S. Rittenhouse, 2000, The Journal of antimicrobial chemotherapy.

Influence of Nutrition on the Morphology of a Strain of Bifidobacterium bifidum

R. Norris, J. Poupard, I. Husain, 1972, Journal of bacteriology.

A review of the antimicrobial activity of clavulanate.

L. Miller, J. Poupard, Jane Finlay, 2003, The Journal of antimicrobial chemotherapy.

Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study.

D. Hoban, G. Zhanel, L. Miller, 2001, Diagnostic microbiology and infectious disease.

Evaluation of two commercially available test methods to determine the feasibility of testing for respiratory syncytial virus in a community hospital laboratory.

J. White, L. Miller, J. Poupard, 1988, American journal of clinical pathology.

Data Mining to Discover Emerging Patterns of Antimicrobic Resistance

J. A. Poupard, Robert C. Gagnon, Michael J. Stanhope, 2005 .

The growth and survivability of Streptococcus pneumoniae clinical isolates subjected to various environmental conditions.

L. Miller, G. Mazzola, J. Poupard, 2003, Diagnostic microbiology and infectious disease.

The Antibiotic Era: Reform, Resistance, and the Pursuit of a Rational Therapeutics

J. Poupard, 2015, Emerging Infectious Diseases.

Methods for Data Mining from Large Multinational Surveillance Studies

M. Stanhope, James J. Brown, J. Poupard, 2002, Antimicrobial Agents and Chemotherapy.

Molecular Evolution Perspectives on Intraspecific Lateral DNA Transfer of Topoisomerase and Gyrase Loci in Streptococcus pneumoniae, with Implications for Fluoroquinolone Resistance Development and Spread

Michael J. Italia, James R. Brown, M. Stanhope, 2005, Antimicrobial Agents and Chemotherapy.

Determination of moxifloxacin anaerobic susceptibility breakpoints according to the Clinical and Laboratory Standards Institute guidelines.

J. Ambler, L. Koeth, R. Rennie, 2008, Diagnostic microbiology and infectious disease.

Comparative In Vitro Surveillance of Amoxicillin-Clavulanic Acid and Four Oral Comparators Against 21,232 Clinical Isolates from Europe

D. Hoban, G. Zhanel, L. Miller, 2003, European Journal of Clinical Microbiology and Infectious Diseases.

In vitro activity of gemifloxacin and contemporary oral antimicrobial agents against 27247 Gram-positive and Gram-negative aerobic isolates: a global surveillance study.

D. Hoban, L. Miller, J. Poupard, 2004, International journal of antimicrobial agents.

Temporal and Spatial Distribution of Clonal Complexes of Streptococcus pneumoniae Isolates Resistant to Multiple Classes of Antibiotics in Belgium, 1997 to 2004

W. Halsey, R. Mera, J. van Eldere, 2008, Antimicrobial Agents and Chemotherapy.

Effect of Storage of Mueller-Hinton Agar Plates on Zone Sizes for Antimicrobial Testing

H. Morton, J. Poupard, L. B. Dewees, 1970 .

Escherichia coli ATCC 35218 as a Quality Control Isolate for Susceptibility Testing of Haemophilus influenzae with Haemophilus Test Medium

L. Miller, J. Poupard, C. Jakielaszek, 1999, Antimicrobial Agents and Chemotherapy.

History of Biological Warfare: Catapults to Capsomeres

J. Poupard, L A Miller, J A Poupard, 1992, Annals of the New York Academy of Sciences.

Inguinal lymphadenitis associated with Capnocytophaga bacilli

J. Poupard, C. C. Johnson, C. Johnson, 1991, Journal of clinical microbiology.

Differences between the activity of penicillin, amoxycillin, and co-amoxyclav against 5,252 Streptococcus pneumoniae isolates tested in the Alexander Project 1992-1996.

L. Miller, J. Poupard, D. Felmingham, 1999, The Journal of antimicrobial chemotherapy.

Risk Factors for Development of Multiple-Class Resistance to Streptococcus pneumoniae Strains in Belgium over a 10-Year Period: Antimicrobial Consumption, Population Density, and Geographic Location (cid:1)

R. Mera, H. Amrine-Madsen, L. Miller, 2007 .

Borrelia burgdorferi and tropical spastic paraparesis

J. Poupard, J. Vernant, G. Buisson, 1990, The Lancet.

Stability of amoxicillin-clavulanate in BACTEC medium determined by high-performance liquid chromatography and bioassay

L. Miller, J. Poupard, T. Moore, 1996, Journal of clinical microbiology.

Update on mupirocin resistance.

J. Poupard, 1995, Journal of chemotherapy.

Antimicrobial Susceptibility Testing

K. Ryan, G. Doern, J. Sherris, 2008, Journal of Clinical Microbiology.

Comparative in vitro potency of amoxycillin-clavulanic acid and four oral agents against recent North American clinical isolates from a global surveillance study.

D. Hoban, G. Zhanel, L. Miller, 2003, International journal of antimicrobial agents.

Antimicrobial Susceptibility Testing

K J Ryan, J C Sherris, K. Ryan, 2016, Advances in Experimental Medicine and Biology.

Infections in the Immunocompromised Host

J. Poupard, A. Evangelista, P. Actor, 1986, Advances in Experimental Medicine and Biology.

Comparison of three methods for determination of a single MIC of an antimicrobial agent

J. Poupard, L A Miller, S F Rittenhouse, 1994, Journal of clinical microbiology.